In agreement with this, Rg3 resisted the NF-κB DNA binding activity, TNF-α-induced transcriptional activation of NF-κB and AP-1 activity and notably promoted apoptosis and sensitivity of chemotherapeutic drugs in colon cancer cells. This evidence concerns the gene NFKB1 and malignant colon neoplasm.